Stock Screener App

Gratuito -

Installare

43.90

0.50% 0.22

after-market

Dopo l'orario di chiusura: 43.90

Corcept Therapeutics Inc (CORT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CORT Giù? Forum Previsione

Corcept Therapeutics Inc Borsa (CORT) Ultime notizie

CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics ... - Caledonian Record

INVESTOR NOTICE: Corcept Therapeutics (CORT) Investors with Substantial Losses Have Opportunity to Lead the Investor Class ActionHagens Berman - Barchart.com

Deadline Alert: Corcept Therapeutics Incorporated (CORT) - GlobeNewswire

Corcept Therapeutics (CORT) climbs 19.7% as Lifyorli gets FDA OK - MSN

Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

CORT 1-WEEK DEADLINE ALERT: Hagens Berman Alerts Corcept - GlobeNewswire

CORT 1-WEEK DEADLINE ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure - GlobeNewswire Inc.

Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors - GlobeNewswire

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - ACCESS Newswire

Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire

Pomerantz LLP Shares Class Action Details With Shareholders in Corcept Therapeutics Incorporated – CORT - ACCESS Newswire

CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure - The Malaysian Reserve

Press releases provided by CNW - Techaeris

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit - PR Newswire

Corcept Leaders Sued Over Drug-Approval Remarks, Stock Sales - Bloomberg Law News

Bragar Eagel & Squire, P.C. Reminds Investors that a Class - GlobeNewswire

Corcept Therapeutics Incorporated Sued for Securities Law - GlobeNewswire

CORT SHAREHOLDER ACTION ALERT: Kaplan Fox Alerts Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026 - NewMediaWire

Corcept's Lifyorli Plus Nab-Paclitaxel Improves Survival in Platinum-Resistant Ovarian Cancer - National Today

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

How The Corcept Therapeutics (CORT) Investment Story Is Shifting After Legal And Regulatory Updates - Yahoo Finance

Corcept’s Lifyorli shows 35% reduction in death risk for ovarian cancer - Investing.com Australia

DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT)Deadline is April 21, 2026 - NewMediaWire

FinancialContentDEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT)Deadline is April 21, 2026 - FinancialContent

Corcept Therapeutics (CORT) Unveils Promising Survival Data from ROSELLA Trial - GuruFocus

Corcept Presents Complete Data from Pivotal ROSELLA Trial in SGO Late-Breaker with Simultaneous Publication in The Lancet: Lifyorli™ (Relacorilant) Plus Nab-Paclitaxel Improves Overall Survival in Patients with Platinum-Resistant Ovarian Cancer - Business Wire

1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds - Yahoo Finance

INVESTOR DEADLINE: Corcept Therapeutics (CORT) Investors - GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Corcept - GlobeNewswire

CORT Shareholder Alert: Corcept Therapeutics Incorporated Securities Class Action Lawsuit ... - Bluefield Daily Telegraph

CORT Shareholder Alert: Corcept Therapeutics Incorporated - GlobeNewswire

Securities Class Action Deadline Against Corcept Therapeutics, Inc. (NASDAQ: CORT)Contact Kaplan Fox Before April 21, 2026 - FinancialContent

Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Corcept Therapeutics (CORT) - The Globe and Mail

CORT Stock Price, Quote & Chart | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill

Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire

Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire

CORT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026 - NewMediaWire

CORT Investors Have Opportunity to Lead Corcept - GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming DeadlinesCORT - PR Newswire

Corcept therapeutics officer Guyer sells $819k in shares By Investing.com - Investing.com UK

Corcept (NASDAQ: CORT) CDO sells 20,000 shares after option exercise - Stock Titan

Corcept (CORT) director Wilson reports 5,000-share stock gift via trust - Stock Titan

CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Inve - The National Law Review

CORT ALERT: Hagens Berman Alerts Corcept Therapeutics - GlobeNewswire

CORT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

CORT INVESTOR ALERT: Investors of Corcept Therapeutics, Inc. (NASDAQ: CORT) Are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on April 21, 2026 - FinancialContent

Corcept Therapeutics Inc (NASDAQ:CORT): An Affordable Growth Stock Built on a Strong Foundation - ChartMill

Corcept Therapeutics Incorporated Securities Fraud Class - GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT - ChartMill

Corcept (CORT) Class Action Alleges Misstatements on FDA Data ConcernsHagens Berman - ChartMill

Insider sells 20,000 CORT shares after option exercise (CORT) - Stock Titan

CORT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

CORT Investors Have Opportunity to Lead Corcept Therapeutics Inc - GuruFocus

Future of Pituitary Cancer Market (2026-2033) | Precision - openPR.com

CORT DEADLINE NOTICE: Corcept Therapeutics Incorporated Investors Encouraged to Contact Kirby McInerney LLP By April 21, 2026 - ACCESS Newswire

Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost M - GuruFocus

MRNA

$54.26

2.69%

RPRX

$48.70

0.25%

BNTX

$99.47

1.08%

RVMD

$152.54

3.76%

INSM

$146.74

4.34%

ONC

$319.94

3.21%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters